ResearcherAgostino Gemelli University PolyclinicNo recent work listed
Davide Cusumano
Matched on ORCID iD 0000-0001-8626-0003; OpenAlex author ID A5033497235. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 5
- The impact of radiomics in diagnosis and staging of pancreatic cancer. Co-author DOI 10.1177/26317745221081596↗
- Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy. Co-author DOI 10.3390/diagnostics11010072↗
- On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. Co-author DOI 10.1016/j.tipsro.2020.06.001↗
- Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. Co-author DOI 10.1002/acm2.12697↗
- Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. First author DOI 10.1186/s13014-019-1275-3↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Luca Boldrini · 5 shared papers, 2019–2022 · strength 0.56
- Paper The impact of radiomics in diagnosis and staging of pancreatic cancer. DOI 10.1177/26317745221081596↗
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. DOI 10.1186/s13014-019-1275-3↗
- Vincenzo Valentini · 5 shared papers, 2019–2022 · strength 0.56
- Paper The impact of radiomics in diagnosis and staging of pancreatic cancer. DOI 10.1177/26317745221081596↗
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. DOI 10.1186/s13014-019-1275-3↗
- Gian Carlo Mattiucci · 4 shared papers, 2019–2022 · strength 0.47
- Paper The impact of radiomics in diagnosis and staging of pancreatic cancer. DOI 10.1177/26317745221081596↗
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. DOI 10.1186/s13014-019-1275-3↗
- Francesco Cellini · 4 shared papers, 2019–2022 · strength 0.45
- Paper The impact of radiomics in diagnosis and staging of pancreatic cancer. DOI 10.1177/26317745221081596↗
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. DOI 10.1186/s13014-019-1275-3↗
- Lorenzo Placidi · 3 shared papers, 2019–2021 · strength 0.31
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Paper Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. DOI 10.1002/acm2.12697↗
- Maria Antonietta Gambacorta · 2 shared papers, 2021–2022 · strength 0.24
- Calogero Casà · 2 shared papers, 2021–2022 · strength 0.24
- Ivo Boškoski · 1 shared paper, 2022 · strength 0.13
- Michael Frederick Bassetti · 1 shared paper, 2021 · strength 0.11
- Marco De Spirito · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.